Cargando…

Functional Aspects of Intrahepatic Hepatitis B Virus-specific T Cells Induced by Therapeutic DNA Vaccination

Current therapies for the hepatitis B virus (HBV), a major cause of severe liver disease, suppress viral replication but replication rebounds if therapy is withdrawn. It is widely accepted that immune activation is needed to control replication off-therapy. To specifically activate T cells crossreac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brass, Anette, Frelin, Lars, Milich, David R, Sällberg, Matti, Ahlén, Gustaf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351461/ https://www.ncbi.nlm.nih.gov/pubmed/25492563 http://dx.doi.org/10.1038/mt.2014.233

Ejemplares similares

A Heterologous Prime/Boost Vaccination Strategy Enhances the Immunogenicity of Therapeutic Vaccines for Hepatitis C Virus
por: Fournillier, Anne, et al.
Publicado: (2013)

Functional differences in hepatitis C virus nonstructural (NS) 3/4A- and 5A-specific T cell responses
por: Holmström, Fredrik, et al.
Publicado: (2016)

Therapeutic DNA Vaccination Using In Vivo Electroporation Followed by Standard of Care Therapy in Patients With Genotype 1 Chronic Hepatitis C
por: Weiland, Ola, et al.
Publicado: (2013)

Immune-mediated effects targeting hepatitis C virus in a syngeneic replicon cell transplantation mouse model
por: Levander, Sepideh, et al.
Publicado: (2018)

A small step closer to the Holy Grail of DNA vaccines: undisputed clinical benefit in humans
por: Frelin, Lars, et al.
Publicado: (2009)

A targeted controlled force injection of genetic material in vivo
por: Ahlén, Gustaf, et al.
Publicado: (2016)

Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance
por: Whitacre, DC, et al.
Publicado: (2019)

Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3
por: Pasetto, Anna, et al.
Publicado: (2012)

Blocking Entry of Hepatitis B and D Viruses to Hepatocytes as a Novel Immunotherapy for Treating Chronic Infections
por: Maravelia, Panagiota, et al.
Publicado: (2020)

Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections
por: Burm, Rani, et al.
Publicado: (2023)

Hepatitis C Virus Nonstructural 3/4A Protein Dampens Inflammation and Contributes to Slow Fibrosis Progression during Chronic Fibrosis In Vivo
por: Bansal, Ruchi, et al.
Publicado: (2015)

The SARS-CoV-2 N Protein Is a Good Component in a Vaccine
por: Ahlén, Gustaf, et al.
Publicado: (2020)

Editorial: HBV—the naked truth?
por: Pasetto, Anna, et al.
Publicado: (2019)

A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells
por: Appelberg, Sofia, et al.
Publicado: (2022)

A DNA-based vaccine protects against Crimean-Congo hemorrhagic fever virus disease in a Cynomolgus macaque model
por: Hawman, David W., et al.
Publicado: (2020)

Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes
por: Ahlén, G, et al.
Publicado: (2009)

Abundance of Noncircular Intrahepatic Hepatitis B Virus DNA May Reflect Frequent Integration Into Human DNA in Chronically Infected Patients
por: Rydell, Gustaf E, et al.
Publicado: (2020)

The Role of Chemokines in Hepatitis C Virus-Mediated Liver Disease
por: Brass, Anette, et al.
Publicado: (2014)

SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation
por: Sandberg, John Tyler, et al.
Publicado: (2021)

Long-term functional duration of immune responses to HCV NS3/4A induced by DNA vaccination
por: Ahlén, G, et al.
Publicado: (2014)

Nucleoside-Modified mRNA Vaccines Protect IFNAR(–/–) Mice against Crimean-Congo Hemorrhagic Fever Virus Infection
por: Appelberg, Sofia, et al.
Publicado: (2022)

Surgical Aspects of Intrahepatic Cholangiocarcinoma
por: Kupietzky, Amram, et al.
Publicado: (2022)

Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation
por: Sällberg, Matti, et al.
Publicado: (2020)

INTRAHEPATIC EXPRESSION OF SERUM HEPATITIS VIRUS-ASSOCIATED ANTIGENS
por: Edgington, Thomas S., et al.
Publicado: (1971)

Long-term follow-up after cure from chronic hepatitis C virus infection shows occult hepatitis and a risk of hepatocellular carcinoma in noncirrhotic patients
por: Lybeck, Charlotte, et al.
Publicado: (2019)

Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment
por: Schlinkert, Richard T., et al.
Publicado: (1992)

A Therapeutic Hepatitis B Virus DNA Vaccine Induces Specific Immune Responses in Mice and Non-Human Primates
por: De Pooter, Dorien, et al.
Publicado: (2021)

Persistence of intrahepatic hepatitis B virus DNA integration in patients developing hepatocellular carcinoma after hepatitis B surface antigen seroclearance
por: Jang, Jeong Won, et al.
Publicado: (2021)

Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma
por: Jeong, Seogsong, et al.
Publicado: (2016)

Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes
por: Song, Zimin, et al.
Publicado: (2023)

Investigation of a Tumor Location-Specific Therapeutic Strategy for Intrahepatic Cholangiocarcinoma
por: Kosaka, Hisashi, et al.
Publicado: (2021)

Review article: emerging insights into the immunopathology, clinical and therapeutic aspects of hepatitis delta virus
por: Usai, Carla, et al.
Publicado: (2022)

Structural aspects of hepatitis E virus
por: Cancela, Florencia, et al.
Publicado: (2022)

Metabolic aspects of hepatitis C virus
por: El-Kassas, Mohamed, et al.
Publicado: (2022)

Hepatitis E Virus (HEV)-Specific T Cell Receptor Cross-Recognition: Implications for Immunotherapy
por: Soon, Chai Fen, et al.
Publicado: (2019)

Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus
por: Tanaka, M, et al.
Publicado: (2010)

The impact of intrahepatic cholestasis of pregnancy with hepatitis B virus infection on perinatal outcomes
por: Hu, Yun, et al.
Publicado: (2014)

Intrahepatic splenosis mimicking hepatic neoplasia
por: Teles, Gabriel Neves Saad, et al.
Publicado: (2018)

Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpox
por: Adamo, Sarah, et al.
Publicado: (2023)

Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_t0n80i0lm6ddt2288h4v2rjqdo